mAbs

译名:单克隆抗体

SCIEJCR Q1

5-10

2026

影响因子区间

平台估算

投稿周期

4%

2025

中国作者发文占比

3150 CHF

费用说明

收费

期刊简介:mAbs is a multi-disciplinary journal dedicated to the art and science of antibody research and development. The journal has a strong scientific and medical focus, but also strives to serve a broader readership. The articles are thus of interest to scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.

【译文】mAbs是一本多学科期刊,致力于抗体研究和开发的技艺与科学。该期刊具有强烈的科学和医学重点,同时也努力服务于更广泛的读者群体。因此,文章对科学家、临床研究人员、医生以及更广泛的mAb社区都感兴趣,包括我们涉及技术转让、法律问题、投资、战略规划和治疗法规的读者。

出版社
Landes Bioscience
语言
English
学科
医学
ISSN
1942-0862
eISSN
1942-0870
出版频率
双月刊
创刊年份
2009
投稿网址
https://www.editorialmanager.com/MABS
最近更新
2026-04-02 18:16:40
mAbs

指标当前值近三年趋势
JCR分区Q1
暂无
影响因子区间5-10
暂无